retatrutide clinical trials efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 retatrutide efficacy clinical trials safety

Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide

Diabetes & metabolism

On a long desert hike, a hot yoga class, or a sweaty day on the bike, you lose sodium, magnesium, potassium, and other minerals that water alone doesn't replace and when those get out of balance, you feel it

When your body digests protein, it releases certain building blocks (called amino acids ) that help trigger GLP-1 production in your gut

Incomplete resections (R1 or R2) are associated with a significantly higher risk of recurrence (Evans et al., 2021)

8 mg per week Produced significant reductions in body weight, making it a potential therapeutic sweet spot